"Molecule ChEMBL ID";"Molecule Name";"Molecule Max Phase";"Molecular Weight";"#RO5 Violations";"AlogP";"Compound Key";"Smiles";"Standard Type";"Standard Relation";"Standard Value";"Standard Units";"pChEMBL Value";"Data Validity Comment";"Comment";"Uo Units";"Ligand Efficiency BEI";"Ligand Efficiency LE";"Ligand Efficiency LLE";"Ligand Efficiency SEI";"Potential Duplicate";"Assay ChEMBL ID";"Assay Description";"Assay Type";"BAO Format ID";"BAO Label";"Assay Organism";"Assay Tissue ChEMBL ID";"Assay Tissue Name";"Assay Cell Type";"Assay Subcellular Fraction";"Assay Parameters";"Assay Variant Accession";"Assay Variant Mutation";"Target ChEMBL ID";"Target Name";"Target Organism";"Target Type";"Document ChEMBL ID";"Source ID";"Source Description";"Document Journal";"Document Year";"Cell ChEMBL ID";"Properties";"Action Type";"Standard Text Value";"Value"
"CHEMBL2111112";"VERNAKALANT";"4.0";"349.47";"0";"2.64";"3759";"COc1ccc(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)cc1OC";"PPB";"";"69.12";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301369";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole guinea pig plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Cavia porcellus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"69.12"
"CHEMBL1945778";"IOFLUPANE";"4.0";"431.29";"0";"3.76";"5832";"COC(=O)[C@H]1[C@@H](c2ccc(I)cc2)C[C@@H]2CC[C@H]1N2CCCF";"PPB";"";"79.92";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"79.92"
"CHEMBL1363";"ARFORMOTEROL";"4.0";"344.41";"0";"2.22";"1800";"COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1";"PPB";"";"31.87";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"31.87"
"CHEMBL113";"CAFFEINE";"4.0";"194.19";"0";"-1.03";"86";"Cn1c(=O)c2c(ncn2C)n(C)c1=O";"PPB";"";"14.52";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"14.52"
"CHEMBL415";"CLOMIPRAMINE";"4.0";"314.86";"0";"4.53";"482";"CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21";"PPB";"";"96.26";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"96.26"
"CHEMBL457";"GEMFIBROZIL";"4.0";"250.34";"0";"3.57";"168";"Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1";"PPB";"";"98.47";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.47"
"CHEMBL121";"ROSIGLITAZONE";"4.0";"357.44";"0";"2.49";"Rosiglitazone";"CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1";"PPB";"";"99.74";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.74"
"CHEMBL118";"CELECOXIB";"4.0";"381.38";"0";"3.51";"1367";"Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1";"PPB";"";"98.94";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.94"
"CHEMBL81";"RALOXIFENE";"4.0";"473.59";"1";"6.08";"Raloxifene";"O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12";"PPB";"";"99.43";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.43"
"CHEMBL1483";"ALBENDAZOLE";"4.0";"265.34";"0";"3.24";"640";"CCCSc1ccc2[nH]c(NC(=O)OC)nc2c1";"PPB";"";"95.43";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"95.43"
"CHEMBL914";"FEXOFENADINE";"4.0";"501.67";"2";"5.51";"2145";"CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"PPB";"";"84.9";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"84.9"
"CHEMBL1789941";"RUXOLITINIB";"4.0";"306.37";"0";"3.47";"B";"N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1";"PPB";"";"94.68";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"94.68"
"CHEMBL267894";"AMOBARBITAL";"4.0";"226.28";"0";"1.18";"403";"CCC1(CCC(C)C)C(=O)NC(=O)NC1=O";"PPB";"";"60.77";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"60.77"
"CHEMBL35";"FUROSEMIDE";"4.0";"330.75";"0";"1.89";"513";"NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl";"PPB";"";"97.95";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"97.95"
"CHEMBL1161";"MOMETASONE FUROATE";"4.0";"521.44";"1";"4.87";"1821";"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)CCl";"PPB";"";"99.7";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.7"
"CHEMBL2181927";"FINERENONE";"4.0";"378.43";"0";"2.99";"5874";"CCOc1ncc(C)c2c1[C@H](c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2";"PPB";"";"99.93";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.93"
"CHEMBL457";"GEMFIBROZIL";"4.0";"250.34";"0";"3.57";"168";"Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1";"PPB";"";"99.77";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.77"
"CHEMBL814";"FLUVOXAMINE";"4.0";"318.34";"0";"3.20";"1858";"COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1";"PPB";"";"75.55";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"75.55"
"CHEMBL1789941";"RUXOLITINIB";"4.0";"306.37";"0";"3.47";"Jakafi";"N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1";"PPB";"";"82.72";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"82.72"
"CHEMBL54";"HALOPERIDOL";"4.0";"375.87";"0";"4.43";"298";"O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1";"PPB";"";"81.36";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"81.36"
"CHEMBL361812";"RAMATROBAN";"4.0";"416.47";"0";"3.09";"2991";"O=C(O)CCn1c2c(c3ccccc31)C[C@H](NS(=O)(=O)c1ccc(F)cc1)CC2";"PPB";"";"95.63";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"95.63"
"CHEMBL1592";"QUINAPRIL";"4.0";"438.52";"0";"2.57";"2854";"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O";"PPB";"";"95.82";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"95.82"
"CHEMBL157101";"KETOCONAZOLE";"4.0";"531.44";"1";"4.21";"2803";"CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1";"PPB";"";"97.2";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"97.2"
"CHEMBL277474";"ANTIPYRINE";"4.0";"188.23";"0";"1.48";"766";"Cc1cc(=O)n(-c2ccccc2)n1C";"PPB";"";"19.35";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"19.35"
"CHEMBL714";"ALBUTEROL";"4.0";"239.31";"0";"1.31";"426";"CC(C)(C)NCC(O)c1ccc(O)c(CO)c1";"PPB";"";"22.79";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"22.79"
"CHEMBL1435";"CEFAZOLIN";"4.0";"454.52";"1";"-0.64";"1749";"Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1";"PPB";"";"27.55";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"27.55"
"CHEMBL644";"TRIMIPRAMINE";"4.0";"294.44";"0";"4.12";"448";"CC(CN(C)C)CN1c2ccccc2CCc2ccccc21";"PPB";"";"93.1";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"93.1"
"CHEMBL742";"KETAMINE";"4.0";"237.73";"0";"2.90";"455";"CNC1(c2ccccc2Cl)CCCCC1=O";"PPB";"";"44.84";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"44.84"
"CHEMBL787";"MONTELUKAST";"4.0";"586.20";"2";"8.95";"3546";"CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1";"PPB";"";"99.95";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.95"
"CHEMBL1282";"IMIQUIMOD";"4.0";"240.31";"0";"2.82";"4110";"CC(C)Cn1cnc2c(N)nc3ccccc3c21";"PPB";"";"99.25";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301368";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole mouse plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Mus musculus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.25"
"CHEMBL81";"RALOXIFENE";"4.0";"473.59";"1";"6.08";"Raloxifene";"O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12";"PPB";"";"99.5";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.5"
"CHEMBL631";"PROPAFENONE";"4.0";"341.45";"0";"3.24";"1517";"CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1";"PPB";"";"95.91";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"95.91"
"CHEMBL2220442";"FLUVASTATIN";"4.0";"411.47";"0";"4.63";"3004";"CC(C)n1c(/C=C/C(O)CC(O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21";"PPB";"";"99.52";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.52"
"CHEMBL158";"AZTREONAM";"4.0";"435.44";"0";"-1.17";"2707";"C[C@H]1[C@H](NC(=O)/C(=N\OC(C)(C)C(=O)O)c2csc(N)n2)C(=O)N1S(=O)(=O)O";"PPB";"";"81.71";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"81.71"
"CHEMBL189963";"PALBOCICLIB";"4.0";"447.54";"0";"2.97";"3446";"CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O";"PPB";"";"77.21";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"77.21"
"CHEMBL72";"DESIPRAMINE";"4.0";"266.39";"0";"3.53";"314";"CNCCCN1c2ccccc2CCc2ccccc21";"PPB";"";"81.01";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"81.01"
"CHEMBL661";"ALPRAZOLAM";"4.0";"308.77";"0";"3.58";"742";"Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2";"PPB";"";"71.05";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"71.05"
"CHEMBL72";"DESIPRAMINE";"4.0";"266.39";"0";"3.53";"314";"CNCCCN1c2ccccc2CCc2ccccc21";"PPB";"";"95.33";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"95.33"
"CHEMBL36";"PYRIMETHAMINE";"4.0";"248.72";"0";"2.52";"Pyrimethamine";"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1";"PPB";"";"93.1";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"93.1"
"CHEMBL741";"LAMOTRIGINE";"4.0";"256.10";"0";"2.01";"152";"Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1";"PPB";"";"55.73";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"55.73"
"CHEMBL22";"TRIMETHOPRIM";"4.0";"290.32";"0";"1.26";"57";"COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC";"PPB";"";"66.1";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"66.1"
"CHEMBL193240";"ROFLUMILAST";"4.0";"403.21";"1";"5.03";"roflumilast";"O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1";"PPB";"";"98.86";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.86"
"CHEMBL8";"CIPROFLOXACIN";"4.0";"331.35";"0";"1.58";"Ciprofloxacin";"O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O";"PPB";"";"31.37";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"31.37"
"CHEMBL42";"CLOZAPINE";"4.0";"326.83";"0";"3.72";"Clozapine";"CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1";"PPB";"";"93.53";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"93.53"
"CHEMBL85";"RISPERIDONE";"4.0";"410.49";"0";"3.59";"Risperidone";"Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2";"PPB";"";"84.6";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"84.6"
"CHEMBL108";"CARBAMAZEPINE";"4.0";"236.27";"0";"3.39";"436";"NC(=O)N1c2ccccc2C=Cc2ccccc21";"PPB";"";"70.58";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"70.58"
"CHEMBL1282";"IMIQUIMOD";"4.0";"240.31";"0";"2.82";"4110";"CC(C)Cn1cnc2c(N)nc3ccccc3c21";"PPB";"";"82.05";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"82.05"
"CHEMBL1287853";"FEDRATINIB";"4.0";"524.69";"1";"4.82";"4876";"Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1";"PPB";"";"80.29";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"80.29"
"CHEMBL384467";"DEXAMETHASONE";"4.0";"392.47";"0";"1.90";"609";"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO";"PPB";"";"87.37";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"87.37"
"CHEMBL423";"BETAXOLOL";"4.0";"307.43";"0";"2.39";"1767";"CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1";"PPB";"";"59.11";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"59.11"
"CHEMBL1017";"TELMISARTAN";"4.0";"514.63";"2";"7.26";"3544";"CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1";"PPB";"";"98.25";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.25"
"CHEMBL1017";"TELMISARTAN";"4.0";"514.63";"2";"7.26";"Telmisartan";"CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1";"PPB";"";"99.23";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.23"
"CHEMBL41";"FLUOXETINE";"4.0";"309.33";"0";"4.44";"Fluoxetine";"CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1";"PPB";"";"94.79";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"94.79"
"CHEMBL841";"LOPERAMIDE";"4.0";"477.05";"1";"5.09";"LOPERAMIDE";"CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1";"PPB";"";"94.56";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"94.56"
"CHEMBL715";"OLANZAPINE";"4.0";"312.44";"0";"3.44";"823";"Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1";"PPB";"";"89.27";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"89.27"
"CHEMBL184";"ACYCLOVIR";"4.0";"225.21";"0";"-1.33";"425";"Nc1nc2c(ncn2COCCO)c(=O)[nH]1";"PPB";"";"10.09";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"10.09"
"CHEMBL106";"FLUCONAZOLE";"4.0";"306.28";"0";"0.74";"1351";"OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F";"PPB";"";"14.23";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"14.23"
"CHEMBL70";"MORPHINE";"4.0";"285.34";"0";"1.20";"1859";"CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5";"PPB";"";"17.28";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"17.28"
"CHEMBL1790041";"RANITIDINE";"4.0";"314.41";"0";"1.46";"1337";"CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1";"PPB";"";"28.95";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"28.95"
"CHEMBL139";"DICLOFENAC";"4.0";"296.15";"0";"4.36";"Diclofenac";"O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl";"PPB";"";"99.68";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.68"
"CHEMBL475534";"NITRENDIPINE";"4.0";"360.37";"0";"2.57";"564";"CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1";"PPB";"";"99.1";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.1"
"CHEMBL1272";"REPAGLINIDE";"4.0";"452.60";"1";"5.22";"3630";"CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(=O)O";"PPB";"";"99.1";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.1"
"CHEMBL36";"PYRIMETHAMINE";"4.0";"248.72";"0";"2.52";"45";"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1";"PPB";"";"92.64";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"92.64"
"CHEMBL19236";"MOXONIDINE";"4.0";"241.68";"0";"0.82";"2273";"COc1nc(C)nc(Cl)c1NC1=NCCN1";"PPB";"";"11.41";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"11.41"
"CHEMBL652";"FLECAINIDE";"4.0";"414.35";"0";"3.44";"1623";"O=C(NCC1CCCCN1)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F";"PPB";"";"42.57";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301369";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole guinea pig plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Cavia porcellus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"42.57"
"CHEMBL742";"KETAMINE";"4.0";"237.73";"0";"2.90";"455";"CNC1(c2ccccc2Cl)CCCCC1=O";"PPB";"";"42.01";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"42.01"
"CHEMBL652";"FLECAINIDE";"4.0";"414.35";"0";"3.44";"1623";"O=C(NCC1CCCCN1)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F";"PPB";"";"46.55";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"46.55"
"CHEMBL1263";"SALMETEROL";"4.0";"415.57";"0";"4.11";"1788";"OCc1cc(C(O)CNCCCCCCOCCCCc2ccccc2)ccc1O";"PPB";"";"93.39";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"93.39"
"CHEMBL2";"PRAZOSIN";"4.0";"383.41";"0";"1.78";"741";"COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC";"PPB";"";"78.41";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"78.41"
"CHEMBL1771";"CLOPIDOGREL";"4.0";"321.83";"0";"3.67";"CLOPIDOGREL";"COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1";"PPB";"";"98.64";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.64"
"CHEMBL479";"THIORIDAZINE";"4.0";"370.59";"1";"5.89";"435";"CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2";"PPB";"";"99.63";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.63"
"CHEMBL1515";"METHIMAZOLE";"4.0";"114.17";"0";"0.71";"488";"Cn1ccnc1S";"PPB";"";"18.64";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"18.64"
"CHEMBL1900528";"TIOTROPIUM";"4.0";"392.52";"0";"2.35";"2996";"C[N+]1(C)[C@@H]2C[C@@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12";"PPB";"";"47.7";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"47.7"
"CHEMBL645";"BISOPROLOL";"4.0";"325.45";"0";"2.37";"1723";"CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1";"PPB";"";"25.75";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"25.75"
"CHEMBL1173055";"RUCAPARIB";"4.0";"323.37";"0";"2.98";"4507";"CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1";"PPB";"";"76.81";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"76.81"
"CHEMBL507674";"CEFOPERAZONE";"4.0";"645.68";"2";"-1.11";"3165";"CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3C(C(=O)O)=C(CSc4nnnn4C)CS[C@H]23)c2ccc(O)cc2)C(=O)C1=O";"PPB";"";"69.12";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"69.12"
"CHEMBL2110732";"DACOMITINIB ANHYDROUS";"4.0";"469.95";"1";"5.16";"5657";"COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1";"PPB";"";"98.21";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.21"
"CHEMBL41355";"EZOGABINE";"4.0";"303.34";"0";"3.59";"1298";"CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)cc1N";"PPB";"";"86.05";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"86.05"
"CHEMBL502";"DONEPEZIL";"4.0";"379.50";"0";"4.36";"430";"COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2";"PPB";"";"89.49";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"89.49"
"CHEMBL21731";"MAPROTILINE";"4.0";"277.41";"0";"4.21";"1372";"CNCCCC12CCC(c3ccccc31)c1ccccc12";"PPB";"";"87.37";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"87.37"
"CHEMBL2";"PRAZOSIN";"4.0";"383.41";"0";"1.78";"741";"COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC";"PPB";"";"96.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"96.0"
"CHEMBL490";"PAROXETINE";"4.0";"329.37";"0";"3.33";"2753";"Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1";"PPB";"";"94.68";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"94.68"
"CHEMBL190";"THEOPHYLLINE";"4.0";"180.17";"0";"-1.04";"583";"Cn1c(=O)c2[nH]cnc2n(C)c1=O";"PPB";"";"43.7";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"43.7"
"CHEMBL914";"FEXOFENADINE";"4.0";"501.67";"2";"5.51";"2145";"CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"PPB";"";"76.81";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"76.81"
"CHEMBL384467";"DEXAMETHASONE";"4.0";"392.47";"0";"1.90";"609";"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO";"PPB";"";"71.53";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"71.53"
"CHEMBL809";"SERTRALINE";"4.0";"306.24";"1";"5.18";"1847";"CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21";"PPB";"";"98.54";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.54"
"CHEMBL1363";"ARFORMOTEROL";"4.0";"344.41";"0";"2.22";"1800";"COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1";"PPB";"";"17.95";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"17.95"
"CHEMBL517";"DISOPYRAMIDE";"4.0";"339.48";"0";"3.36";"396";"CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C";"PPB";"";"33.39";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"33.39"
"CHEMBL193";"NIFEDIPINE";"4.0";"346.34";"0";"2.18";"197";"COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-]";"PPB";"";"99.77";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.77"
"CHEMBL1463345";"CANRENONE";"4.0";"340.46";"0";"4.37";"4162";"C[C@]12CCC(=O)C=C1C=C[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@@]21CCC(=O)O1";"PPB";"";"96.17";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"96.17"
"CHEMBL126";"LINEZOLID";"4.0";"337.35";"0";"1.12";"267";"CC(=O)NC[C@H]1CN(c2ccc(N3CCOCC3)c(F)c2)C(=O)O1";"PPB";"";"22.79";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"22.79"
"CHEMBL1473";"FLUTICASONE PROPIONATE";"4.0";"500.58";"1";"4.43";"1748";"CCC(=O)O[C@]1(C(=O)SCF)[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C";"PPB";"";"98.84";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.84"
"CHEMBL193240";"ROFLUMILAST";"4.0";"403.21";"1";"5.03";"2902";"O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1";"PPB";"";"99.5";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.5"
"CHEMBL16";"PHENYTOIN";"4.0";"252.27";"0";"1.77";"782";"O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1";"PPB";"";"87.11";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"87.11"
"CHEMBL896";"HYDROXYZINE";"4.0";"374.91";"0";"3.06";"1335";"OCCOCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1";"PPB";"";"91.82";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"91.82"
"CHEMBL573";"NIACIN";"4.0";"123.11";"0";"0.78";"103";"O=C(O)c1cccnc1";"PPB";"";"45.41";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"45.41"
"CHEMBL1059";"PREGABALIN";"4.0";"159.23";"0";"1.08";"2606";"CC(C)C[C@H](CN)CC(=O)O";"PPB";"";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"50.0"
"CHEMBL1738797";"ALECTINIB";"4.0";"482.63";"0";"4.77";"5725";"CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O";"PPB";"";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"50.0"
"CHEMBL219916";"DOMPERIDONE";"4.0";"425.92";"0";"3.35";"1754";"O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1";"PPB";"";"93.1";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"93.1"
"CHEMBL2181927";"FINERENONE";"4.0";"378.43";"0";"2.99";"5874";"CCOc1ncc(C)c2c1[C@H](c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2";"PPB";"";"92.48";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"92.48"
"CHEMBL193";"NIFEDIPINE";"4.0";"346.34";"0";"2.18";"197";"COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-]";"PPB";"";"92.64";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"92.64"
"CHEMBL500";"PINDOLOL";"4.0";"248.33";"0";"1.91";"85";"CC(C)NCC(O)COc1cccc2[nH]ccc12";"PPB";"";"41.45";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"41.45"
"CHEMBL1484";"NICARDIPINE";"4.0";"479.53";"0";"3.68";"833";"COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1";"PPB";"";"99.61";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.61"
"CHEMBL957";"BOSENTAN";"4.0";"551.63";"1";"4.20";"707";"COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)nc(-c2ncccn2)nc1OCCO";"PPB";"";"98.78";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.78"
"CHEMBL472";"GLYBURIDE";"4.0";"494.01";"0";"3.64";"454";"COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1";"PPB";"";"99.73";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301368";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole mouse plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Mus musculus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.73"
"CHEMBL1672";"CEFPODOXIME";"4.0";"427.46";"0";"-0.54";"5856";"COCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\OC)c3csc(N)n3)[C@H]2SC1";"PPB";"";"53.45";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"53.45"
"CHEMBL1672";"CEFPODOXIME";"4.0";"427.46";"0";"-0.54";"5856";"COCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\OC)c3csc(N)n3)[C@H]2SC1";"PPB";"";"54.59";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"54.59"
"CHEMBL88";"CYCLOPHOSPHAMIDE ANHYDROUS";"4.0";"261.09";"0";"1.88";"Cyclophosphamide";"O=P1(N(CCCl)CCCl)NCCCO1";"PPB";"";"14.23";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"14.23"
"CHEMBL981";"FENOFIBRIC ACID";"4.0";"318.76";"0";"3.81";"441";"CC(C)(Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1)C(=O)O";"PPB";"";"98.81";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.81"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"5699";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"PPB";"";"99.05";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.05"
"CHEMBL479";"THIORIDAZINE";"4.0";"370.59";"1";"5.89";"435";"CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2";"PPB";"";"99.3";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.3"
"CHEMBL51";"KETANSERIN";"4.0";"395.43";"0";"2.42";"804";"O=C(c1ccc(F)cc1)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1";"PPB";"";"99.36";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.36"
"CHEMBL914";"FEXOFENADINE";"4.0";"501.67";"2";"5.51";"2145";"CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"PPB";"";"62.94";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"62.94"
"CHEMBL407";"FLUMAZENIL";"4.0";"303.29";"0";"1.77";"232";"CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(F)ccc1-2";"PPB";"";"55.73";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"55.73"
"CHEMBL841";"LOPERAMIDE";"4.0";"477.05";"1";"5.09";"683";"CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1";"PPB";"";"96.42";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301368";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole mouse plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Mus musculus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"96.42"
"CHEMBL1464";"WARFARIN";"4.0";"308.33";"0";"3.61";"WARFARIN";"CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O";"PPB";"";"99.31";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.31"
"CHEMBL42";"CLOZAPINE";"4.0";"326.83";"0";"3.72";"211";"CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1";"PPB";"";"94.79";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"94.79"
"CHEMBL1346";"DARIFENACIN";"4.0";"426.56";"0";"3.96";"3453";"NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(CCc2ccc3c(c2)CCO3)C1";"PPB";"";"92.16";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"92.16"
"CHEMBL726";"FLUPHENAZINE";"4.0";"437.53";"0";"4.31";"472";"OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1";"PPB";"";"98.81";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.81"
"CHEMBL726";"FLUPHENAZINE";"4.0";"437.53";"0";"4.31";"472";"OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1";"PPB";"";"98.81";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.81"
"CHEMBL1020";"TOLMETIN";"4.0";"257.29";"0";"2.19";"254";"Cc1ccc(C(=O)c2ccc(CC(=O)O)n2C)cc1";"PPB";"";"99.72";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.72"
"CHEMBL75880";"PERHEXILINE";"4.0";"277.50";"1";"5.30";"1357";"C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1";"PPB";"";"98.44";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.44"
"CHEMBL567";"PERPHENAZINE";"4.0";"403.98";"0";"3.94";"SID170464834";"OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1";"PPB";"";"98.54";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.54"
"CHEMBL1428";"NIMODIPINE";"4.0";"418.45";"0";"2.97";"1829";"COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1";"PPB";"";"98.84";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.84"
"CHEMBL1292";"CLOFAZIMINE";"4.0";"473.41";"1";"7.49";"1336";"CC(C)/N=c1\cc2n(-c3ccc(Cl)cc3)c3ccccc3nc-2cc1Nc1ccc(Cl)cc1";"PPB";"";"99.63";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.63"
"CHEMBL865";"VALDECOXIB";"4.0";"314.37";"0";"2.96";"3892";"Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1";"PPB";"";"97.55";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"97.55"
"CHEMBL219916";"DOMPERIDONE";"4.0";"425.92";"0";"3.35";"1754";"O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1";"PPB";"";"96.65";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"96.65"
"CHEMBL1542";"AZATHIOPRINE";"4.0";"277.27";"0";"1.15";"373";"Cn1cnc([N+](=O)[O-])c1Sc1ncnc2[nH]cnc12";"PPB";"";"67.63";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"67.63"
"CHEMBL655";"MIDAZOLAM";"4.0";"325.77";"0";"4.32";"1215";"Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2";"PPB";"";"98.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.0"
"CHEMBL453";"SULFISOXAZOLE";"4.0";"267.31";"0";"1.67";"99";"Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C";"PPB";"";"98.47";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.47"
"CHEMBL2216870";"IDELALISIB";"4.0";"415.43";"0";"3.75";"5676";"CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1";"PPB";"";"81.01";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301368";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole mouse plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Mus musculus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"81.01"
"CHEMBL865";"VALDECOXIB";"4.0";"314.37";"0";"2.96";"valdecoxib";"Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1";"PPB";"";"94.56";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301369";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole guinea pig plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Cavia porcellus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"94.56"
"CHEMBL866";"MYCOPHENOLIC ACID";"4.0";"320.34";"0";"2.73";"1823";"COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)O)C(=O)OC2";"PPB";"";"98.4";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.4"
"CHEMBL12";"DIAZEPAM";"4.0";"284.75";"0";"3.15";"370";"CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21";"PPB";"";"98.61";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.61"
"CHEMBL35";"FUROSEMIDE";"4.0";"330.75";"0";"1.89";"513";"NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl";"PPB";"";"98.37";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.37"
"CHEMBL114";"SAQUINAVIR";"4.0";"670.86";"1";"3.09";"3716";"CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1";"PPB";"";"98.86";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.86"
"CHEMBL898";"DIFLUNISAL";"4.0";"250.20";"0";"3.04";"592";"O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O";"PPB";"";"99.82";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.82"
"CHEMBL21731";"MAPROTILINE";"4.0";"277.41";"0";"4.21";"1372";"CNCCCC12CCC(c3ccccc31)c1ccccc12";"PPB";"";"92.16";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"92.16"
"CHEMBL2070241";"BREMELANOTIDE";"4.0";"1025.18";"None";"None";"4684";"CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@@H](C(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC1=O";"PPB";"";"27.09";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"27.09"
"CHEMBL1900528";"TIOTROPIUM";"4.0";"392.52";"0";"2.35";"2996";"C[N+]1(C)[C@@H]2C[C@@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12";"PPB";"";"38.69";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301369";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole guinea pig plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Cavia porcellus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"38.69"
"CHEMBL190";"THEOPHYLLINE";"4.0";"180.17";"0";"-1.04";"583";"Cn1c(=O)c2[nH]cnc2n(C)c1=O";"PPB";"";"43.14";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"43.14"
"CHEMBL32";"MOXIFLOXACIN";"4.0";"401.44";"0";"2.37";"2737";"COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12";"PPB";"";"23.19";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301369";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole guinea pig plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Cavia porcellus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"23.19"
"CHEMBL8";"CIPROFLOXACIN";"4.0";"331.35";"0";"1.58";"Ciprofloxacin";"O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O";"PPB";"";"43.14";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"43.14"
"CHEMBL34259";"METHOTREXATE";"4.0";"454.45";"0";"0.27";"1230";"CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1";"PPB";"";"46.55";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"46.55"
"CHEMBL1112";"ARIPIPRAZOLE";"4.0";"448.39";"0";"4.86";"3196";"O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1";"PPB";"";"99.91";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.91"
"CHEMBL1144";"PRAVASTATIN";"4.0";"424.53";"0";"2.44";"577";"CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21";"PPB";"";"65.06";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"65.06"
"CHEMBL49";"BUSPIRONE";"4.0";"385.51";"0";"2.09";"Buspirone";"O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1";"PPB";"";"67.12";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"67.12"
"CHEMBL198362";"RIVAROXABAN";"4.0";"435.89";"0";"2.52";"2584";"O=C(NC[C@H]1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1";"PPB";"";"94.56";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"94.56"
"CHEMBL1164729";"FEBUXOSTAT";"4.0";"316.38";"0";"3.72";"4028";"Cc1nc(-c2ccc(OCC(C)C)c(C#N)c2)sc1C(=O)O";"PPB";"";"99.48";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.48"
"CHEMBL114";"SAQUINAVIR";"4.0";"670.86";"1";"3.09";"3716";"CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1";"PPB";"";"99.52";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.52"
"CHEMBL1484";"NICARDIPINE";"4.0";"479.53";"0";"3.68";"833";"COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1";"PPB";"";"99.6";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.6"
"CHEMBL1471";"APREPITANT";"4.0";"534.43";"1";"4.95";"2535";"C[C@@H](O[C@H]1OCCN(Cc2n[nH]c(=O)[nH]2)[C@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1";"PPB";"";"99.77";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.77"
"CHEMBL1789941";"RUXOLITINIB";"4.0";"306.37";"0";"3.47";"4675";"N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1";"PPB";"";"83.37";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"83.37"
"CHEMBL54";"HALOPERIDOL";"4.0";"375.87";"0";"4.43";"1 (Haloperidol)";"O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1";"PPB";"";"85.48";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"85.48"
"CHEMBL6966";"VERAPAMIL";"4.0";"454.61";"1";"5.09";"verapamil";"COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC";"PPB";"";"86.05";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"86.05"
"CHEMBL1078178";"MOMELOTINIB";"4.0";"414.47";"0";"2.98";"5472";"N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1";"PPB";"";"89.7";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"89.7"
"CHEMBL445";"NORTRIPTYLINE";"4.0";"263.38";"0";"3.83";"429";"CNCCC=C1c2ccccc2CCc2ccccc21";"PPB";"";"86.85";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"86.85"
"CHEMBL490";"PAROXETINE";"4.0";"329.37";"0";"3.33";"2753";"Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1";"PPB";"";"89.91";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"89.91"
"CHEMBL472";"GLYBURIDE";"4.0";"494.01";"0";"3.64";"454";"COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1";"PPB";"";"99.88";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.88"
"CHEMBL841";"LOPERAMIDE";"4.0";"477.05";"1";"5.09";"683";"CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1";"PPB";"";"92.64";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"92.64"
"CHEMBL580";"LORAZEPAM";"4.0";"321.16";"0";"3.10";"848";"O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O";"PPB";"";"92.8";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"92.8"
"CHEMBL1483";"ALBENDAZOLE";"4.0";"265.34";"0";"3.24";"640";"CCCSc1ccc2[nH]c(NC(=O)OC)nc2c1";"PPB";"";"94.19";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"94.19"
"CHEMBL1518";"PROPYLTHIOURACIL";"4.0";"170.24";"0";"1.38";"55";"CCCc1cc(=O)[nH]c(=S)[nH]1";"PPB";"";"37.6";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"37.6"
"CHEMBL1518";"PROPYLTHIOURACIL";"4.0";"170.24";"0";"1.38";"55";"CCCc1cc(=O)[nH]c(=S)[nH]1";"PPB";"";"40.89";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"40.89"
"CHEMBL498";"CHLORPROPAMIDE";"4.0";"276.75";"0";"1.74";"480";"CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1";"PPB";"";"85.77";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"85.77"
"CHEMBL621";"TRAZODONE";"4.0";"371.87";"0";"2.36";"405";"O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12";"PPB";"";"87.62";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"87.62"
"CHEMBL11";"IMIPRAMINE";"4.0";"280.42";"0";"3.88";"Imipramine";"CN(C)CCCN1c2ccccc2CCc2ccccc21";"PPB";"";"87.87";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"87.87"
"CHEMBL1560";"CAPTOPRIL";"4.0";"217.29";"0";"0.63";"1442";"C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O";"PPB";"";"90.12";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"90.12"
"CHEMBL1000";"CETIRIZINE";"4.0";"388.90";"0";"3.15";"1886";"O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1";"PPB";"";"90.12";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"90.12"
"CHEMBL2111112";"VERNAKALANT";"4.0";"349.47";"0";"2.64";"vernakalant";"COc1ccc(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)cc1OC";"PPB";"";"22.38";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"22.38"
"CHEMBL714";"ALBUTEROL";"4.0";"239.31";"0";"1.31";"426";"CC(C)(C)NCC(O)c1ccc(O)c(CO)c1";"PPB";"";"14.52";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301369";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole guinea pig plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Cavia porcellus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"14.52"
"CHEMBL1020";"TOLMETIN";"4.0";"257.29";"0";"2.19";"254";"Cc1ccc(C(=O)c2ccc(CC(=O)O)n2C)cc1";"PPB";"";"95.23";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"95.23"
"CHEMBL715";"OLANZAPINE";"4.0";"312.44";"0";"3.44";"823";"Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1";"PPB";"";"87.62";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"87.62"
"CHEMBL669";"CYCLOBENZAPRINE";"4.0";"275.40";"0";"4.55";"1385";"CN(C)CCC=C1c2ccccc2C=Cc2ccccc21";"PPB";"";"92.16";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"92.16"
"CHEMBL1027";"TIAGABINE";"4.0";"375.56";"1";"5.04";"1780";"Cc1ccsc1C(=CCCN1CCC[C@@H](C(=O)O)C1)c1sccc1C";"PPB";"";"94.9";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"94.9"
"CHEMBL1201335";"GLYCOPYRRONIUM";"4.0";"318.44";"0";"2.46";"3445";"C[N+]1(C)CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1";"PPB";"";"31.87";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"31.87"
"CHEMBL894";"BUPROPION";"4.0";"239.75";"0";"3.30";"1609";"CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1";"PPB";"";"45.98";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"45.98"
"CHEMBL1072";"BUMETANIDE";"4.0";"364.42";"0";"3.04";"1506";"CCCCNc1cc(C(=O)O)cc(S(N)(=O)=O)c1Oc1ccccc1";"PPB";"";"96.34";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"96.34"
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"5735";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"PPB";"";"96.57";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"96.57"
"CHEMBL605846";"OLODATEROL";"4.0";"386.45";"0";"2.38";"5606";"COc1ccc(CC(C)(C)NC[C@H](O)c2cc(O)cc3c2OCC(=O)N3)cc1";"PPB";"";"59.11";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"59.11"
"CHEMBL23";"DILTIAZEM";"4.0";"414.53";"0";"3.37";"632";"COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1";"PPB";"";"75.97";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"75.97"
"CHEMBL502";"DONEPEZIL";"4.0";"379.50";"0";"4.36";"430";"COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2";"PPB";"";"66.1";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"66.1"
"CHEMBL475534";"NITRENDIPINE";"4.0";"360.37";"0";"2.57";"564";"CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1";"PPB";"";"99.23";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.23"
"CHEMBL1161";"MOMETASONE FUROATE";"4.0";"521.44";"1";"4.87";"1821";"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)CCl";"PPB";"";"99.77";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.77"
"CHEMBL832";"SULFINPYRAZONE";"4.0";"404.49";"0";"3.80";"2940";"O=C1C(CC[S+]([O-])c2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1";"PPB";"";"99.77";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.77"
"CHEMBL972";"SELEGILINE";"4.0";"187.29";"0";"2.18";"3007";"C#CCN(C)[C@H](C)Cc1ccccc1";"PPB";"";"72.91";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"72.91"
"CHEMBL9967";"PIRENZEPINE";"4.0";"351.41";"0";"1.56";"174";"CN1CCN(CC(=O)N2c3ccccc3C(=O)Nc3cccnc32)CC1";"PPB";"";"24.03";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"24.03"
"CHEMBL451";"CHLORDIAZEPOXIDE";"4.0";"299.76";"0";"2.95";"841";"CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1";"PPB";"";"97.71";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"97.71"
"CHEMBL1428";"NIMODIPINE";"4.0";"418.45";"0";"2.97";"1829";"COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1";"PPB";"";"98.17";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.17"
"CHEMBL1263";"SALMETEROL";"4.0";"415.57";"0";"4.11";"1788";"OCc1cc(C(O)CNCCCCCCOCCCCc2ccccc2)ccc1O";"PPB";"";"98.21";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.21"
"CHEMBL1513";"IRBESARTAN";"4.0";"428.54";"0";"4.78";"2271";"CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1";"PPB";"";"98.54";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.54"
"CHEMBL957";"BOSENTAN";"4.0";"551.63";"1";"4.20";"707";"COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)nc(-c2ncccn2)nc1OCCO";"PPB";"";"98.7";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.7"
"CHEMBL1263";"SALMETEROL";"4.0";"415.57";"0";"4.11";"1788";"OCc1cc(C(O)CNCCCCCCOCCCCc2ccccc2)ccc1O";"PPB";"";"95.23";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301369";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole guinea pig plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Cavia porcellus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"95.23"
"CHEMBL1346";"DARIFENACIN";"4.0";"426.56";"0";"3.96";"3453";"NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(CCc2ccc3c(c2)CCO3)C1";"PPB";"";"89.91";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301369";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole guinea pig plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Cavia porcellus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"89.91"
"CHEMBL15023";"TRIFLUPERIDOL";"4.0";"409.42";"0";"4.79";"1576";"O=C(CCCN1CCC(O)(c2cccc(C(F)(F)F)c2)CC1)c1ccc(F)cc1";"PPB";"";"89.05";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"89.05"
"CHEMBL1027";"TIAGABINE";"4.0";"375.56";"1";"5.04";"1780";"Cc1ccsc1C(=CCCN1CCC[C@@H](C(=O)O)C1)c1sccc1C";"PPB";"";"91.64";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"91.64"
"CHEMBL113";"CAFFEINE";"4.0";"194.19";"0";"-1.03";"86";"Cn1c(=O)c2c(ncn2C)n(C)c1=O";"PPB";"";"13.68";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"13.68"
"CHEMBL406";"INDAPAMIDE";"4.0";"365.84";"0";"2.08";"1384";"CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1";"PPB";"";"79.55";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"79.55"
"CHEMBL192";"SILDENAFIL";"4.0";"474.59";"0";"1.61";"2407";"CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12";"PPB";"";"82.39";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"82.39"
"CHEMBL1201753";"PITAVASTATIN";"4.0";"421.47";"0";"4.52";"1191";"O=C(O)C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1";"PPB";"";"98.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.0"
"CHEMBL553";"ERLOTINIB";"4.0";"393.44";"0";"3.41";"80";"C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1";"PPB";"";"95.82";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"95.82"
"CHEMBL193";"NIFEDIPINE";"4.0";"346.34";"0";"2.18";"197";"COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-]";"PPB";"";"96.17";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"96.17"
"CHEMBL1113";"AMOXAPINE";"4.0";"313.79";"0";"3.43";"1518";"Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2";"PPB";"";"89.91";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"89.91"
"CHEMBL184412";"DRONEDARONE";"4.0";"556.77";"2";"7.05";"2597";"CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1";"PPB";"";"99.91";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.91"
"CHEMBL1276308";"MIFEPRISTONE";"4.0";"429.60";"1";"5.41";"2658";"CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C";"PPB";"";"99.85";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.85"
"CHEMBL122";"ROFECOXIB";"4.0";"314.36";"0";"2.56";"rofecoxib";"CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1";"PPB";"";"93.1";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"93.1"
"CHEMBL1346";"DARIFENACIN";"4.0";"426.56";"0";"3.96";"3453";"NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(CCc2ccc3c(c2)CCO3)C1";"PPB";"";"95.12";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"95.12"
"CHEMBL71";"CHLORPROMAZINE";"4.0";"318.87";"0";"4.89";"11";"CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21";"PPB";"";"98.64";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.64"
"CHEMBL1697";"DILTIAZEM HYDROCHLORIDE";"4.0";"450.99";"0";"3.37";"2634";"COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1.Cl";"PPB";"";"35.46";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"35.46"
"CHEMBL1423";"PIMOZIDE";"4.0";"461.56";"1";"5.86";"469";"O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1";"PPB";"";"99.7";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.7"
"CHEMBL2220442";"FLUVASTATIN";"4.0";"411.47";"0";"4.63";"3004";"CC(C)n1c(/C=C/C(O)CC(O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21";"PPB";"";"99.72";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.72"
"CHEMBL1464";"WARFARIN";"4.0";"308.33";"0";"3.61";"511";"CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O";"PPB";"";"96.79";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"96.79"
"CHEMBL473";"DOFETILIDE";"4.0";"441.58";"0";"1.98";"1615";"CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1";"PPB";"";"66.1";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"66.1"
"CHEMBL139";"DICLOFENAC";"4.0";"296.15";"0";"4.36";"667";"O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl";"PPB";"";"99.28";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.28"
"CHEMBL571";"KETOPROFEN";"4.0";"254.29";"0";"3.11";"735";"CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1";"PPB";"";"99.36";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.36"
"CHEMBL1073";"GLIPIZIDE";"4.0";"445.55";"0";"2.08";"973";"Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1";"PPB";"";"99.12";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.12"
"CHEMBL49";"BUSPIRONE";"4.0";"385.51";"0";"2.09";"295";"O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1";"PPB";"";"77.62";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"77.62"
"CHEMBL421";"SULFASALAZINE";"4.0";"398.40";"0";"3.70";"1493";"O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O";"PPB";"";"99.71";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.71"
"CHEMBL1073";"GLIPIZIDE";"4.0";"445.55";"0";"2.08";"973";"Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1";"PPB";"";"97.76";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"97.76"
"CHEMBL1491";"AMLODIPINE";"4.0";"408.88";"0";"2.27";"1352";"CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl";"PPB";"";"98.09";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.09"
"CHEMBL1473";"FLUTICASONE PROPIONATE";"4.0";"500.58";"1";"4.43";"1748";"CCC(=O)O[C@]1(C(=O)SCF)[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C";"PPB";"";"98.09";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.09"
"CHEMBL643";"PROMETHAZINE";"4.0";"284.43";"0";"4.24";"117";"CC(CN1c2ccccc2Sc2ccccc21)N(C)C";"PPB";"";"92.95";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"92.95"
"CHEMBL652";"FLECAINIDE";"4.0";"414.35";"0";"3.44";"1623";"O=C(NCC1CCCCN1)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F";"PPB";"";"38.14";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"38.14"
"CHEMBL642";"ACEBUTOLOL";"4.0";"336.43";"0";"2.37";"788";"CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1";"PPB";"";"28.95";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"28.95"
"CHEMBL1088";"MESORIDAZINE";"4.0";"386.59";"0";"4.90";"866";"CN1CCCCC1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21";"PPB";"";"92.32";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"92.32"
"CHEMBL1441";"ETHIONAMIDE";"4.0";"166.25";"0";"1.28";"1539";"CCc1cc(C(N)=S)ccn1";"PPB";"";"45.98";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"45.98"
"CHEMBL86";"METOCLOPRAMIDE";"4.0";"299.80";"0";"2.00";"393";"CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC";"PPB";"";"29.9";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"29.9"
"CHEMBL16073";"PHENACETIN";"4.0";"179.22";"0";"2.04";"505";"CCOc1ccc(NC(C)=O)cc1";"PPB";"";"34.94";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"34.94"
"CHEMBL741";"LAMOTRIGINE";"4.0";"256.10";"0";"2.01";"152";"Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1";"PPB";"";"48.85";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"48.85"
"CHEMBL453";"SULFISOXAZOLE";"4.0";"267.31";"0";"1.67";"99";"Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C";"PPB";"";"91.28";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"91.28"
"CHEMBL1628227";"DOXEPIN";"4.0";"279.38";"0";"3.96";"2999";"CN(C)CCC=C1c2ccccc2COc2ccccc21";"PPB";"";"76.39";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"76.39"
"CHEMBL1201195";"CEFMETAZOLE";"4.0";"471.55";"1";"-0.73";"2696";"CO[C@@]1(NC(=O)CSCC#N)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@@H]21";"PPB";"";"80.65";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"80.65"
"CHEMBL11";"IMIPRAMINE";"4.0";"280.42";"0";"3.88";"490";"CN(C)CCCN1c2ccccc2CCc2ccccc21";"PPB";"";"82.72";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"82.72"
"CHEMBL435";"HYDROCHLOROTHIAZIDE";"4.0";"297.75";"0";"-0.35";"521";"NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O";"PPB";"";"71.99";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"71.99"
"CHEMBL361812";"RAMATROBAN";"4.0";"416.47";"0";"3.09";"2991";"O=C(O)CCn1c2c(c3ccccc31)C[C@H](NS(=O)(=O)c1ccc(F)cc1)CC2";"PPB";"";"97.26";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"97.26"
"CHEMBL192";"SILDENAFIL";"4.0";"474.59";"0";"1.61";"2407";"CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12";"PPB";"";"90.12";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"90.12"
"CHEMBL51";"KETANSERIN";"4.0";"395.43";"0";"2.42";"ketanserin";"O=C(c1ccc(F)cc1)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1";"PPB";"";"90.32";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"90.32"
"CHEMBL35";"FUROSEMIDE";"4.0";"330.75";"0";"1.89";"513";"NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl";"PPB";"";"96.93";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"96.93"
"CHEMBL567";"PERPHENAZINE";"4.0";"403.98";"0";"3.94";"444";"OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1";"PPB";"";"98.51";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.51"
"CHEMBL1628227";"DOXEPIN";"4.0";"279.38";"0";"3.96";"2999";"CN(C)CCC=C1c2ccccc2COc2ccccc21";"PPB";"";"79.55";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"79.55"
"CHEMBL41355";"EZOGABINE";"4.0";"303.34";"0";"3.59";"1298";"CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)cc1N";"PPB";"";"79.92";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"79.92"
"CHEMBL1297";"FENOPROFEN";"4.0";"242.27";"0";"3.67";"780";"CC(C(=O)O)c1cccc(Oc2ccccc2)c1";"PPB";"";"98.54";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.54"
"CHEMBL571";"KETOPROFEN";"4.0";"254.29";"0";"3.11";"735";"CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1";"PPB";"";"98.73";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.73"
"CHEMBL422";"TRIFLUOPERAZINE";"4.0";"407.51";"0";"4.95";"871";"CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1";"PPB";"";"99.3";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.3"
"CHEMBL1473";"FLUTICASONE PROPIONATE";"4.0";"500.58";"1";"4.43";"1748";"CCC(=O)O[C@]1(C(=O)SCF)[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C";"PPB";"";"98.47";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.47"
"CHEMBL1463345";"CANRENONE";"4.0";"340.46";"0";"4.37";"4162";"C[C@]12CCC(=O)C=C1C=C[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@@]21CCC(=O)O1";"PPB";"";"94.06";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"94.06"
"CHEMBL1294";"QUINIDINE";"4.0";"324.42";"0";"3.17";"1231";"C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12";"PPB";"";"85.48";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"85.48"
"CHEMBL549";"CITALOPRAM";"4.0";"324.40";"0";"3.81";"717";"CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21";"PPB";"";"59.66";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"59.66"
"CHEMBL1404";"RANOLAZINE";"4.0";"427.55";"0";"2.31";"2213";"COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1";"PPB";"";"53.45";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"53.45"
"CHEMBL1201335";"GLYCOPYRRONIUM";"4.0";"318.44";"0";"2.46";"3445";"C[N+]1(C)CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1";"PPB";"";"20.83";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301369";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole guinea pig plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Cavia porcellus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"20.83"
"CHEMBL642";"ACEBUTOLOL";"4.0";"336.43";"0";"2.37";"788";"CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1";"PPB";"";"21.21";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"21.21"
"CHEMBL645";"BISOPROLOL";"4.0";"325.45";"0";"2.37";"1723";"CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1";"PPB";"";"23.19";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"23.19"
"CHEMBL2111112";"VERNAKALANT";"4.0";"349.47";"0";"2.64";"3759";"COc1ccc(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)cc1OC";"PPB";"";"37.06";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"37.06"
"CHEMBL941";"IMATINIB";"4.0";"493.62";"0";"4.59";"309";"Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1";"PPB";"";"93.67";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"93.67"
"CHEMBL2181927";"FINERENONE";"4.0";"378.43";"0";"2.99";"5874";"CCOc1ncc(C)c2c1[C@H](c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2";"PPB";"";"99.93";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301368";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole mouse plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Mus musculus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.93"
"CHEMBL1077896";"ROPIVACAINE";"4.0";"274.41";"0";"3.51";"1782";"CCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C";"PPB";"";"48.85";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"48.85"
"CHEMBL475534";"NITRENDIPINE";"4.0";"360.37";"0";"2.57";"564";"CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1";"PPB";"";"98.92";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.92"
"CHEMBL255044";"FLUPIRTINE";"4.0";"304.32";"0";"2.98";"694";"CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)nc1N";"PPB";"";"78.01";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"78.01"
"CHEMBL49";"BUSPIRONE";"4.0";"385.51";"0";"2.09";"295";"O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1";"PPB";"";"75.12";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"75.12"
"CHEMBL1525826";"SULFALENE";"4.0";"280.31";"0";"0.87";"1188";"COc1nccnc1NS(=O)(=O)c1ccc(N)cc1";"PPB";"";"76.81";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"76.81"
"CHEMBL95";"TACRINE";"4.0";"198.27";"0";"2.70";"315";"Nc1c2c(nc3ccccc13)CCCC2";"PPB";"";"53.45";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"53.45"
"CHEMBL130";"CHLORAMPHENICOL";"4.0";"323.13";"0";"0.91";"1673";"O=C(N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(Cl)Cl";"PPB";"";"56.3";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"56.3"
"CHEMBL429";"LABETALOL";"4.0";"328.41";"0";"2.14";"1068";"CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1";"PPB";"";"62.4";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"62.4"
"CHEMBL408";"TROGLITAZONE";"4.0";"441.55";"0";"4.37";"SID170465091";"Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2";"PPB";"";"99.91";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.91"
"CHEMBL1071";"OXAPROZIN";"4.0";"293.32";"0";"4.03";"102";"O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1";"PPB";"";"99.76";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.76"
"CHEMBL154";"NAPROXEN";"4.0";"230.26";"0";"3.04";"2878";"COc1ccc2cc([C@H](C)C(=O)O)ccc2c1";"PPB";"";"99.8";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.8"
"CHEMBL277474";"ANTIPYRINE";"4.0";"188.23";"0";"1.48";"ANTIPYRINE";"Cc1cc(=O)n(-c2ccccc2)n1C";"PPB";"";"14.52";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"14.52"
"CHEMBL1071";"OXAPROZIN";"4.0";"293.32";"0";"4.03";"102";"O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1";"PPB";"";"99.95";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.95"
"CHEMBL1435";"CEFAZOLIN";"4.0";"454.52";"1";"-0.64";"1749";"Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1";"PPB";"";"90.32";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"90.32"
"CHEMBL655";"MIDAZOLAM";"4.0";"325.77";"0";"4.32";"1215";"Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2";"PPB";"";"95.43";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"95.43"
"CHEMBL568";"OXAZEPAM";"4.0";"286.72";"0";"2.45";"445";"O=C1Nc2ccc(Cl)cc2C(c2ccccc2)=NC1O";"PPB";"";"96.17";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"96.17"
"CHEMBL832";"SULFINPYRAZONE";"4.0";"404.49";"0";"3.80";"2940";"O=C1C(CC[S+]([O-])c2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1";"PPB";"";"99.31";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.31"
"CHEMBL1201753";"PITAVASTATIN";"4.0";"421.47";"0";"4.52";"1191";"O=C(O)C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1";"PPB";"";"99.36";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.36"
"CHEMBL81";"RALOXIFENE";"4.0";"473.59";"1";"6.08";"536";"O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12";"PPB";"";"99.5";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.5"
"CHEMBL2103846";"ULIPRISTAL";"4.0";"433.59";"0";"4.97";"5938";"CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C";"PPB";"";"99.51";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.51"
"CHEMBL554";"LAPATINIB";"4.0";"581.07";"2";"6.14";"Lapatinib";"CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1";"PPB";"";"99.74";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.74"
"CHEMBL472";"GLYBURIDE";"4.0";"494.01";"0";"3.64";"454";"COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1";"PPB";"";"99.88";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.88"
"CHEMBL1287853";"FEDRATINIB";"4.0";"524.69";"1";"4.82";"4876";"Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1";"PPB";"";"79.55";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"79.55"
"CHEMBL70972";"SERATRODAST";"4.0";"354.45";"0";"4.61";"3152";"CC1=C(C)C(=O)C(C(CCCCCC(=O)O)c2ccccc2)=C(C)C1=O";"PPB";"";"98.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.0"
"CHEMBL782";"TOLBUTAMIDE";"4.0";"270.35";"0";"1.78";"122";"CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1";"PPB";"";"98.09";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.09"
"CHEMBL1428";"NIMODIPINE";"4.0";"418.45";"0";"2.97";"1829";"COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1";"PPB";"";"98.25";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.25"
"CHEMBL480";"LANSOPRAZOLE";"4.0";"369.37";"0";"3.52";"SID855954";"Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c1nc2ccccc2[nH]1";"PPB";"";"98.4";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.4"
"CHEMBL1900528";"TIOTROPIUM";"4.0";"392.52";"0";"2.35";"2996";"C[N+]1(C)[C@@H]2C[C@@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12";"PPB";"";"19.35";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"19.35"
"CHEMBL473";"DOFETILIDE";"4.0";"441.58";"0";"1.98";"1615";"CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1";"PPB";"";"69.61";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"69.61"
"CHEMBL564";"PROMAZINE";"4.0";"284.43";"0";"4.24";"339";"CN(C)CCCN1c2ccccc2Sc2ccccc21";"PPB";"";"89.91";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"89.91"
"CHEMBL669";"CYCLOBENZAPRINE";"4.0";"275.40";"0";"4.55";"1385";"CN(C)CCC=C1c2ccccc2C=Cc2ccccc21";"PPB";"";"88.35";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"88.35"
"CHEMBL1000";"CETIRIZINE";"4.0";"388.90";"0";"3.15";"1886";"O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1";"PPB";"";"81.01";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"81.01"
"CHEMBL16";"PHENYTOIN";"4.0";"252.27";"0";"1.77";"782";"O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1";"PPB";"";"82.05";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"82.05"
"CHEMBL611";"TERAZOSIN";"4.0";"387.44";"0";"1.06";"1702";"COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC";"PPB";"";"79.55";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"79.55"
"CHEMBL650";"METHYLPREDNISOLONE";"4.0";"374.48";"0";"1.80";"2659";"C[C@H]1C[C@@H]2[C@H]([C@@H](O)C[C@@]3(C)[C@H]2CC[C@]3(O)C(=O)CO)[C@@]2(C)C=CC(=O)C=C12";"PPB";"";"79.92";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"79.92"
"CHEMBL1113";"AMOXAPINE";"4.0";"313.79";"0";"3.43";"1518";"Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2";"PPB";"";"89.05";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"89.05"
"CHEMBL934";"METYRAPONE";"4.0";"226.28";"0";"2.64";"526";"CC(C)(C(=O)c1cccnc1)c1cccnc1";"PPB";"";"11.18";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"11.18"
"CHEMBL1294";"QUINIDINE";"4.0";"324.42";"0";"3.17";"1231";"C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12";"PPB";"";"60.77";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"60.77"
"CHEMBL498";"CHLORPROPAMIDE";"4.0";"276.75";"0";"1.74";"480";"CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1";"PPB";"";"96.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"96.0"
"CHEMBL72";"DESIPRAMINE";"4.0";"266.39";"0";"3.53";"314";"CNCCCN1c2ccccc2CCc2ccccc21";"PPB";"";"85.19";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"85.19"
"CHEMBL1172";"DESLORATADINE";"4.0";"310.83";"0";"4.02";"1721";"Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1";"PPB";"";"85.48";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"85.48"
"CHEMBL589586";"MONOMETHYL FUMARATE";"4.0";"130.10";"0";"-0.20";"128";"COC(=O)/C=C/C(=O)O";"PPB";"";"86.05";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"86.05"
"CHEMBL708";"ZIPRASIDONE";"4.0";"412.95";"0";"3.81";"1138";"O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1";"PPB";"";"99.7";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.7"
"CHEMBL637";"VENLAFAXINE";"4.0";"277.41";"0";"3.04";"1883";"COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1";"PPB";"";"18.64";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"18.64"
"CHEMBL1515";"METHIMAZOLE";"4.0";"114.17";"0";"0.71";"488";"Cn1ccnc1S";"PPB";"";"18.99";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"18.99"
"CHEMBL1017";"TELMISARTAN";"4.0";"514.63";"2";"7.26";"3544";"CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1";"PPB";"";"99.62";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.62"
"CHEMBL1464";"WARFARIN";"4.0";"308.33";"0";"3.61";"511";"CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O";"PPB";"";"99.21";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.21"
"CHEMBL1109";"SULFAPHENAZOLE";"4.0";"314.37";"0";"2.26";"512";"Nc1ccc(S(=O)(=O)Nc2ccnn2-c2ccccc2)cc1";"PPB";"";"99.41";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.41"
"CHEMBL192";"SILDENAFIL";"4.0";"474.59";"0";"1.61";"2407";"CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12";"PPB";"";"95.53";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"95.53"
"CHEMBL601719";"CRIZOTINIB";"4.0";"450.35";"1";"5.04";"4095";"C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl";"PPB";"";"95.53";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"95.53"
"CHEMBL41";"FLUOXETINE";"4.0";"309.33";"0";"4.44";"605";"CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1";"PPB";"";"95.72";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"95.72"
"CHEMBL71";"CHLORPROMAZINE";"4.0";"318.87";"0";"4.89";"CPZ";"CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21";"PPB";"";"98.29";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.29"
"CHEMBL1201335";"GLYCOPYRRONIUM";"4.0";"318.44";"0";"2.46";"3445";"C[N+]1(C)CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1";"PPB";"";"28.95";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"28.95"
"CHEMBL361812";"RAMATROBAN";"4.0";"416.47";"0";"3.09";"2991";"O=C(O)CCn1c2c(c3ccccc31)C[C@H](NS(=O)(=O)c1ccc(F)cc1)CC2";"PPB";"";"96.72";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"96.72"
"CHEMBL1422";"SITAGLIPTIN";"4.0";"407.32";"0";"2.02";"3325";"N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F";"PPB";"";"28.95";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301368";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole mouse plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Mus musculus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"28.95"
"CHEMBL621";"TRAZODONE";"4.0";"371.87";"0";"2.36";"405";"O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12";"PPB";"";"97.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"97.0"
"CHEMBL708";"ZIPRASIDONE";"4.0";"412.95";"0";"3.81";"1138";"O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1";"PPB";"";"99.9";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.9"
"CHEMBL1172";"DESLORATADINE";"4.0";"310.83";"0";"4.02";"1721";"Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1";"PPB";"";"81.71";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301368";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole mouse plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Mus musculus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"81.71"
"CHEMBL163";"RITONAVIR";"4.0";"720.96";"2";"5.91";"4156";"CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1";"PPB";"";"96.72";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"96.72"
"CHEMBL1072";"BUMETANIDE";"4.0";"364.42";"0";"3.04";"1506";"CCCCNc1cc(C(=O)O)cc(S(N)(=O)=O)c1Oc1ccccc1";"PPB";"";"98.44";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.44"
"CHEMBL1231";"OXYBUTYNIN";"4.0";"357.49";"0";"3.34";"1379";"CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1";"PPB";"";"97.07";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"97.07"
"CHEMBL1020";"TOLMETIN";"4.0";"257.29";"0";"2.19";"254";"Cc1ccc(C(=O)c2ccc(CC(=O)O)n2C)cc1";"PPB";"";"97.13";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"97.13"
"CHEMBL507674";"CEFOPERAZONE";"4.0";"645.68";"2";"-1.11";"3165";"CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3C(C(=O)O)=C(CSc4nnnn4C)CS[C@H]23)c2ccc(O)cc2)C(=O)C1=O";"PPB";"";"90.12";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"90.12"
"CHEMBL6966";"VERAPAMIL";"4.0";"454.61";"1";"5.09";"305";"COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC";"PPB";"";"89.27";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"89.27"
"CHEMBL416";"METHOXSALEN";"4.0";"216.19";"0";"2.55";"891";"COc1c2occc2cc2ccc(=O)oc12";"PPB";"";"92.32";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"92.32"
"CHEMBL88";"CYCLOPHOSPHAMIDE ANHYDROUS";"4.0";"261.09";"0";"1.88";"88";"O=P1(N(CCCl)CCCl)NCCCO1";"PPB";"";"20.08";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"20.08"
"CHEMBL70";"MORPHINE";"4.0";"285.34";"0";"1.20";"1859";"CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5";"PPB";"";"20.83";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"20.83"
"CHEMBL1422";"SITAGLIPTIN";"4.0";"407.32";"0";"2.02";"3325";"N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F";"PPB";"";"23.19";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"23.19"
"CHEMBL126";"LINEZOLID";"4.0";"337.35";"0";"1.12";"267";"CC(=O)NC[C@H]1CN(c2ccc(N3CCOCC3)c(F)c2)C(=O)O1";"PPB";"";"23.19";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301368";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole mouse plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Mus musculus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"23.19"
"CHEMBL32";"MOXIFLOXACIN";"4.0";"401.44";"0";"2.37";"2737";"COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12";"PPB";"";"30.88";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"30.88"
"CHEMBL46";"ONDANSETRON";"4.0";"293.37";"0";"3.13";"177";"Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O";"PPB";"";"36.53";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301369";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole guinea pig plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Cavia porcellus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"36.53"
"CHEMBL549";"CITALOPRAM";"4.0";"324.40";"0";"3.81";"717";"CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21";"PPB";"";"37.06";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301369";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole guinea pig plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Cavia porcellus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"37.06"
"CHEMBL57";"NEVIRAPINE";"4.0";"266.30";"0";"2.65";"3290";"Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1";"PPB";"";"44.27";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"44.27"
"CHEMBL445";"NORTRIPTYLINE";"4.0";"263.38";"0";"3.83";"429";"CNCCC=C1c2ccccc2CCc2ccccc21";"PPB";"";"86.85";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"86.85"
"CHEMBL108";"CARBAMAZEPINE";"4.0";"236.27";"0";"3.39";"436";"NC(=O)N1c2ccccc2C=Cc2ccccc21";"PPB";"";"73.36";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"73.36"
"CHEMBL113";"CAFFEINE";"4.0";"194.19";"0";"-1.03";"86";"Cn1c(=O)c2c(ncn2C)n(C)c1=O";"PPB";"";"24.45";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"24.45"
"CHEMBL832";"SULFINPYRAZONE";"4.0";"404.49";"0";"3.80";"2940";"O=C1C(CC[S+]([O-])c2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1";"PPB";"";"94.32";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"94.32"
"CHEMBL1201753";"PITAVASTATIN";"4.0";"421.47";"0";"4.52";"1191";"O=C(O)C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1";"PPB";"";"97.07";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"97.07"
"CHEMBL8";"CIPROFLOXACIN";"4.0";"331.35";"0";"1.58";"ciprofloxacin";"O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O";"PPB";"";"34.42";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"34.42"
"CHEMBL32";"MOXIFLOXACIN";"4.0";"401.44";"0";"2.37";"2737";"COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12";"PPB";"";"34.42";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"34.42"
"CHEMBL855";"TRIPROLIDINE";"4.0";"278.40";"0";"3.92";"2534";"Cc1ccc(/C(=C\CN2CCCC2)c2ccccn2)cc1";"PPB";"";"35.46";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"35.46"
"CHEMBL502";"DONEPEZIL";"4.0";"379.50";"0";"4.36";"donepezil";"COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2";"PPB";"";"38.69";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"38.69"
"CHEMBL549";"CITALOPRAM";"4.0";"324.40";"0";"3.81";"717";"CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21";"PPB";"";"48.85";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301368";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole mouse plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Mus musculus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"48.85"
"CHEMBL422";"TRIFLUOPERAZINE";"4.0";"407.51";"0";"4.95";"871";"CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1";"PPB";"";"99.19";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.19"
"CHEMBL340978";"BENOXAPROFEN";"4.0";"301.73";"0";"4.34";"261";"CC(C(=O)O)c1ccc2oc(-c3ccc(Cl)cc3)nc2c1";"PPB";"";"99.76";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.76"
"CHEMBL126";"LINEZOLID";"4.0";"337.35";"0";"1.12";"267";"CC(=O)NC[C@H]1CN(c2ccc(N3CCOCC3)c(F)c2)C(=O)O1";"PPB";"";"22.38";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"22.38"
"CHEMBL184";"ACYCLOVIR";"4.0";"225.21";"0";"-1.33";"425";"Nc1nc2c(ncn2COCCO)c(=O)[nH]1";"PPB";"";"25.75";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"25.75"
"CHEMBL945";"AMILORIDE";"4.0";"229.63";"0";"-1.08";"227";"N=C(N)NC(=O)c1nc(Cl)c(N)nc1N";"PPB";"";"27.09";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"27.09"
"CHEMBL826";"ENOXACIN";"4.0";"320.32";"0";"0.66";"1381";"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21";"PPB";"";"34.42";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"34.42"
"CHEMBL558";"MEXILETINE";"4.0";"179.26";"0";"2.03";"1369";"Cc1cccc(C)c1OCC(C)N";"PPB";"";"36.53";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"36.53"
"CHEMBL1161";"MOMETASONE FUROATE";"4.0";"521.44";"1";"4.87";"1821";"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)CCl";"PPB";"";"99.9";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.9"
"CHEMBL126";"LINEZOLID";"4.0";"337.35";"0";"1.12";"LINEZOLID";"CC(=O)NC[C@H]1CN(c2ccc(N3CCOCC3)c(F)c2)C(=O)O1";"PPB";"";"52.3";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"52.3"
"CHEMBL549";"CITALOPRAM";"4.0";"324.40";"0";"3.81";"717";"CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21";"PPB";"";"56.3";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"56.3"
"CHEMBL17157";"TERFENADINE";"4.0";"471.69";"1";"6.45";"1573";"CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"PPB";"";"99.16";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.16"
"CHEMBL108";"CARBAMAZEPINE";"4.0";"236.27";"0";"3.39";"436";"NC(=O)N1c2ccccc2C=Cc2ccccc21";"PPB";"";"72.91";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"72.91"
"CHEMBL782";"TOLBUTAMIDE";"4.0";"270.35";"0";"1.78";"122";"CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1";"PPB";"";"97.71";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"97.71"
"CHEMBL1069";"VALSARTAN";"4.0";"435.53";"0";"4.16";"1764";"CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)[C@H](C(=O)O)C(C)C";"PPB";"";"98.64";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.64"
"CHEMBL723";"CARVEDILOL";"4.0";"406.48";"0";"3.74";"1768";"COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12";"PPB";"";"97.38";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"97.38"
"CHEMBL1294";"QUINIDINE";"4.0";"324.42";"0";"3.17";"1231";"C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12";"PPB";"";"93.8";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"93.8"
"CHEMBL6966";"VERAPAMIL";"4.0";"454.61";"1";"5.09";"305";"COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC";"PPB";"";"89.91";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301368";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole mouse plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Mus musculus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"89.91"
"CHEMBL219916";"DOMPERIDONE";"4.0";"425.92";"0";"3.35";"1754";"O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1";"PPB";"";"91.28";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"91.28"
"CHEMBL2107834";"RIOCIGUAT";"4.0";"422.42";"0";"2.44";"5392";"COC(=O)N(C)c1c(N)nc(-c2nn(Cc3ccccc3F)c3ncccc23)nc1N";"PPB";"";"91.46";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"91.46"
"CHEMBL601719";"CRIZOTINIB";"4.0";"450.35";"1";"5.04";"4095";"C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl";"PPB";"";"92.16";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"92.16"
"CHEMBL15023";"TRIFLUPERIDOL";"4.0";"409.42";"0";"4.79";"1576";"O=C(CCCN1CCC(O)(c2cccc(C(F)(F)F)c2)CC1)c1ccc(F)cc1";"PPB";"";"92.32";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"92.32"
"CHEMBL1263";"SALMETEROL";"4.0";"415.57";"0";"4.11";"1788";"OCc1cc(C(O)CNCCCCCCOCCCCc2ccccc2)ccc1O";"PPB";"";"92.64";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"92.64"
"CHEMBL631";"PROPAFENONE";"4.0";"341.45";"0";"3.24";"1517";"CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1";"PPB";"";"92.95";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"92.95"
"CHEMBL945";"AMILORIDE";"4.0";"229.63";"0";"-1.08";"227";"N=C(N)NC(=O)c1nc(Cl)c(N)nc1N";"PPB";"";"31.37";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"31.37"
"CHEMBL85";"RISPERIDONE";"4.0";"410.49";"0";"3.59";"1057";"Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2";"PPB";"";"94.56";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"94.56"
"CHEMBL941";"IMATINIB";"4.0";"493.62";"0";"4.59";"309";"Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1";"PPB";"";"97.2";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"97.2"
"CHEMBL23";"DILTIAZEM";"4.0";"414.53";"0";"3.37";"632";"COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1";"PPB";"";"65.06";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"65.06"
"CHEMBL42";"CLOZAPINE";"4.0";"326.83";"0";"3.72";"211";"CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1";"PPB";"";"91.28";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301369";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole guinea pig plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Cavia porcellus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"91.28"
"CHEMBL190";"THEOPHYLLINE";"4.0";"180.17";"0";"-1.04";"583";"Cn1c(=O)c2[nH]cnc2n(C)c1=O";"PPB";"";"14.81";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"14.81"
"CHEMBL42";"CLOZAPINE";"4.0";"326.83";"0";"3.72";"211";"CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1";"PPB";"";"92.64";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"92.64"
"CHEMBL601719";"CRIZOTINIB";"4.0";"450.35";"1";"5.04";"4095";"C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl";"PPB";"";"94.79";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"94.79"
"CHEMBL1477";"CERIVASTATIN";"4.0";"459.56";"0";"4.88";"cerivastatin";"COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c1-c1ccc(F)cc1";"PPB";"";"94.9";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"94.9"
"CHEMBL744";"RILUZOLE";"4.0";"234.20";"0";"2.78";"670";"Nc1nc2ccc(OC(F)(F)F)cc2s1";"PPB";"";"97.13";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"97.13"
"CHEMBL112";"ACETAMINOPHEN";"4.0";"151.16";"0";"1.35";"81";"CC(=O)Nc1ccc(O)cc1";"PPB";"";"26.64";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"26.64"
"CHEMBL1900528";"TIOTROPIUM";"4.0";"392.52";"0";"2.35";"2996";"C[N+]1(C)[C@@H]2C[C@@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12";"PPB";"";"47.7";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"47.7"
"CHEMBL1191";"SULFAMETHIZOLE";"4.0";"270.34";"0";"1.23";"706";"Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1";"PPB";"";"93.53";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"93.53"
"CHEMBL1282";"IMIQUIMOD";"4.0";"240.31";"0";"2.82";"4110";"CC(C)Cn1cnc2c(N)nc3ccccc3c21";"PPB";"";"85.19";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"85.19"
"CHEMBL11";"IMIPRAMINE";"4.0";"280.42";"0";"3.88";"490";"CN(C)CCCN1c2ccccc2CCc2ccccc21";"PPB";"";"95.63";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"95.63"
"CHEMBL255044";"FLUPIRTINE";"4.0";"304.32";"0";"2.98";"694";"CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)nc1N";"PPB";"";"84.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"84.0"
"CHEMBL646";"TRIAZOLAM";"4.0";"343.22";"0";"4.23";"865";"Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2";"PPB";"";"85.48";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"85.48"
"CHEMBL453";"SULFISOXAZOLE";"4.0";"267.31";"0";"1.67";"99";"Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C";"PPB";"";"86.59";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"86.59"
"CHEMBL325041";"BORTEZOMIB";"4.0";"384.25";"None";"None";"5064";"CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O";"PPB";"";"86.85";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"86.85"
"CHEMBL12";"DIAZEPAM";"4.0";"284.75";"0";"3.15";"370";"CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21";"PPB";"";"87.62";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"87.62"
"CHEMBL549";"CITALOPRAM";"4.0";"324.40";"0";"3.81";"717";"CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21";"PPB";"";"59.66";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"59.66"
"CHEMBL1363";"ARFORMOTEROL";"4.0";"344.41";"0";"2.22";"1800";"COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1";"PPB";"";"60.77";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"60.77"
"CHEMBL506";"PRIMAQUINE";"4.0";"259.35";"0";"2.78";"108";"COc1cc(NC(C)CCCN)c2ncccc2c1";"PPB";"";"59.66";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"59.66"
"CHEMBL1464";"WARFARIN";"4.0";"308.33";"0";"3.61";"511";"CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O";"PPB";"";"96.87";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301369";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole guinea pig plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Cavia porcellus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"96.87"
"CHEMBL809";"SERTRALINE";"4.0";"306.24";"1";"5.18";"1847";"CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21";"PPB";"";"98.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.0"
"CHEMBL296419";"ASTEMIZOLE";"4.0";"458.58";"1";"5.35";"1378";"COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1";"PPB";"";"97.38";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"97.38"
"CHEMBL655";"MIDAZOLAM";"4.0";"325.77";"0";"4.32";"1215";"Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2";"PPB";"";"98.25";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"98.25"
"CHEMBL573";"NIACIN";"4.0";"123.11";"0";"0.78";"103";"O=C(O)c1cccnc1";"PPB";"";"44.84";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"44.84"
"CHEMBL1214";"CARBENICILLIN";"4.0";"378.41";"0";"0.49";"2933";"CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)O)c3ccccc3)C(=O)N2[C@H]1C(=O)O";"PPB";"";"45.41";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"45.41"
"CHEMBL638";"VORICONAZOLE";"4.0";"349.32";"0";"2.18";"483";"C[C@@H](c1ncncc1F)[C@](O)(Cn1cncn1)c1ccc(F)cc1F";"PPB";"";"46.55";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"46.55"
"CHEMBL473";"DOFETILIDE";"4.0";"441.58";"0";"1.98";"DOFETILIDE";"CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1";"PPB";"";"51.15";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301369";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole guinea pig plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Cavia porcellus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"51.15"
"CHEMBL1477";"CERIVASTATIN";"4.0";"459.56";"0";"4.88";"1116";"COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c1-c1ccc(F)cc1";"PPB";"";"99.01";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.01"
"CHEMBL605846";"OLODATEROL";"4.0";"386.45";"0";"2.38";"5606";"COc1ccc(CC(C)(C)NC[C@H](O)c2cc(O)cc3c2OCC(=O)N3)cc1";"PPB";"";"55.73";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"55.73"
"CHEMBL481";"IRINOTECAN";"4.0";"586.69";"1";"4.09";"2980";"CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC";"PPB";"";"57.99";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"57.99"
"CHEMBL1069";"VALSARTAN";"4.0";"435.53";"0";"4.16";"1764";"CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)[C@H](C(=O)O)C(C)C";"PPB";"";"99.78";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.78"
"CHEMBL1422";"SITAGLIPTIN";"4.0";"407.32";"0";"2.02";"1";"N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F";"PPB";"";"21.99";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"21.99"
"CHEMBL2111112";"VERNAKALANT";"4.0";"349.47";"0";"2.64";"3759";"COc1ccc(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)cc1OC";"PPB";"";"22.79";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"22.79"
"CHEMBL423";"BETAXOLOL";"4.0";"307.43";"0";"2.39";"1767";"CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1";"PPB";"";"27.55";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"27.55"
"CHEMBL277474";"ANTIPYRINE";"4.0";"188.23";"0";"1.48";"766";"Cc1cc(=O)n(-c2ccccc2)n1C";"PPB";"";"29.9";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"29.9"
"CHEMBL714";"ALBUTEROL";"4.0";"239.31";"0";"1.31";"426";"CC(C)(C)NCC(O)c1ccc(O)c(CO)c1";"PPB";"";"34.42";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"34.42"
"CHEMBL108";"CARBAMAZEPINE";"4.0";"236.27";"0";"3.39";"SID124879629";"NC(=O)N1c2ccccc2C=Cc2ccccc21";"PPB";"";"75.97";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301369";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole guinea pig plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Cavia porcellus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"75.97"
"CHEMBL1144";"PRAVASTATIN";"4.0";"424.53";"0";"2.44";"577";"CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21";"PPB";"";"39.23";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"39.23"
"CHEMBL1000";"CETIRIZINE";"4.0";"388.90";"0";"3.15";"cetirizine";"O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1";"PPB";"";"40.34";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301369";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole guinea pig plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Cavia porcellus";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"40.34"
"CHEMBL898";"DIFLUNISAL";"4.0";"250.20";"0";"3.04";"592";"O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O";"PPB";"";"99.79";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"99.79"
"CHEMBL507674";"CEFOPERAZONE";"4.0";"645.68";"2";"-1.11";"3165";"CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3C(C(=O)O)=C(CSc4nnnn4C)CS[C@H]23)c2ccc(O)cc2)C(=O)C1=O";"PPB";"";"32.37";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301367";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Canis lupus familiaris";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"32.37"
"CHEMBL558";"MEXILETINE";"4.0";"179.26";"0";"2.03";"1369";"Cc1cccc(C)c1OCC(C)N";"PPB";"";"36.53";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"36.53"
"CHEMBL1444";"LETROZOLE";"4.0";"285.31";"0";"2.66";"2016";"N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1";"PPB";"";"51.73";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3301365";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Homo sapiens";"CHEMBL3559721";"Plasma";"None";"None";"";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca DMPK/physicochemical";"";"";"None";"";"";"";"51.73"
